본문 바로가기

A multicenter, randomized, active-controlled, clinical trial study to evaluate the efficacy and safety of navigation guided balloon Eustachian tuboplasty

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
SCIENTIFIC REPORTS11(1) · 2021
피인용
Web of Science 15Scopus 20
FWCI (Scopus)
0.41
JCR IF
JCR 2020 4.38
ISSN
2045-2322

저자

  1. 최성원제1저자Pusan Natl Univ, Pusan Natl Univ Hosp, Biomed Res Inst, Dept Otorhinolaryngol Head & Neck Surg,Sch Med, Gudeok Ro 179, Busan 49241, South Korea
  2. 오세준Pusan Natl Univ, Pusan Natl Univ Hosp, Biomed Res Inst, Dept Otorhinolaryngol Head & Neck Surg,Sch Med, Gudeok Ro 179, Busan 49241, South Korea
  3. Kim, YehreeUniv Ulsan, Dept Otorhinolaryngol Head & Neck Surg, Asan Med Ctr, Coll Med, Seoul, South Korea
  4. Kwak, Min YoungEulji Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Daejeon, South Korea
  5. Suh, Myung-WhanSeoul Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea
  6. Park, Moo KyunSeoul Natl Univ, Seoul Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea
  7. Lee, Chi KyouSoonchunhyang Univ, Cheonan Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Cheonan, South Korea
  8. Park, Hong JuUniv Ulsan, Dept Otorhinolaryngol Head & Neck Surg, Asan Med Ctr, Coll Med, Seoul, South Korea
  9. 공수근교신저자Pusan Natl Univ, Pusan Natl Univ Hosp, Biomed Res Inst, Dept Otorhinolaryngol Head & Neck Surg,Sch Med, Gudeok Ro 179, Busan 49241, South Korea

초록

© 2021, The Author(s).To assess the safety and efficacy of navigation-guided balloon Eustachian tuboplasty (BET) compared to medical management (MM) alone in patients with chronic Eustachian tube dilatory dysfunction (ETD). This is a prospective, multicenter, 1:1 parallel-group, randomized controlled trial (RCT). It aims to assess the efficacy of navigation-guided BET compared to MM alone in patients with chronic ETD. The primary outcome measure was an improvement in the Eustachian tube dysfunction questionnaire (ETDQ)-7 score at the 6-week follow-up compared with baseline. Secondary outcome measures included changes in the signs and symptoms during the follow-up, changes in the score for each subcategory of ETDQ-7, type of tympanometry, pure tone audiometry, and the availability of a positive modified Valsalva maneuver. Navigation-guided BET was safely performed in all patients. A total of 38 ears of 31 patients (19 ears of 16 patients in the BET group and 19 ears of 15 patients in the control group) completed the planned treatment and 6 weeks of follow-up. More patients in the BET group (1.99 ± 0.85) had less symptomatic dysfunction than in the control group (3.40 ± 1.29) at 6 weeks post-procedure (P = 0.001). More patients experienced tympanogram improvement in the BET group at 6 weeks compared to the control group (36.5% vs. 15.8%) with a positive modified Valsalva maneuver (36.6% vs. 15.8%, P = 0.014). Additionally, air–bone gap change was significantly decreased in the BET group compared to the control group at the 6-week follow-up visit (P = 0.037). This prospective, multicenter, RCT study suggests that navigation-guided BET is a safe and superior treatment option compared to MM alone in patients with chronic ETD.

키워드

TUBE DYSFUNCTIONOTITIS-MEDIADILATIONEFFUSION

식별자

Scopus EID
2-s2.0-85120803517
WoS UID
000728529200090